Table of Content

1 Market Overview of Irritable Bowel Syndrome Drug
1.1 Irritable Bowel Syndrome Drug Market Overview
1.1.1 Irritable Bowel Syndrome Drug Product Scope
1.1.2 Irritable Bowel Syndrome Drug Market Status and Outlook
1.2 Global Irritable Bowel Syndrome Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Irritable Bowel Syndrome Drug Market Size by Region (2018-2029)
1.4 Global Irritable Bowel Syndrome Drug Historic Market Size by Region (2018-2024)
1.5 Global Irritable Bowel Syndrome Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.6.1 North America Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.6.2 Europe Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.6.4 Latin America Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Irritable Bowel Syndrome Drug Market Size (2018-2029)
2 Irritable Bowel Syndrome Drug Market by Type
2.1 Introduction
2.1.1 IBS-D Drugs
2.1.2 IBS-C Drugs
2.1.3 Others
2.2 Global Irritable Bowel Syndrome Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Irritable Bowel Syndrome Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Irritable Bowel Syndrome Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Irritable Bowel Syndrome Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Irritable Bowel Syndrome Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Irritable Bowel Syndrome Drug Revenue Breakdown by Type (2018-2029)
3 Irritable Bowel Syndrome Drug Market Overview by Application
3.1 Introduction
3.1.1 Women
3.1.2 Men
3.2 Global Irritable Bowel Syndrome Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Irritable Bowel Syndrome Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Irritable Bowel Syndrome Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Irritable Bowel Syndrome Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Irritable Bowel Syndrome Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Irritable Bowel Syndrome Drug Revenue Breakdown by Application (2018-2029)
4 Irritable Bowel Syndrome Drug Competition Analysis by Players
4.1 Global Irritable Bowel Syndrome Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2022)
4.3 Date of Key Players Enter into Irritable Bowel Syndrome Drug Market
4.4 Global Top Players Irritable Bowel Syndrome Drug Headquarters and Area Served
4.5 Key Players Irritable Bowel Syndrome Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Irritable Bowel Syndrome Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ironwood Pharmaceuticals
5.1.1 Ironwood Pharmaceuticals Profile
5.1.2 Ironwood Pharmaceuticals Main Business
5.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Products, Services and Solutions
5.1.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Ironwood Pharmaceuticals Recent Developments
5.2 Bausch Health
5.2.1 Bausch Health Profile
5.2.2 Bausch Health Main Business
5.2.3 Bausch Health Irritable Bowel Syndrome Drug Products, Services and Solutions
5.2.4 Bausch Health Irritable Bowel Syndrome Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Bausch Health Recent Developments
5.3 Takeda
5.3.1 Takeda Profile
5.3.2 Takeda Main Business
5.3.3 Takeda Irritable Bowel Syndrome Drug Products, Services and Solutions
5.3.4 Takeda Irritable Bowel Syndrome Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Sebela Pharmaceuticals Recent Developments
5.4 Sebela Pharmaceuticals
5.4.1 Sebela Pharmaceuticals Profile
5.4.2 Sebela Pharmaceuticals Main Business
5.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Products, Services and Solutions
5.4.4 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Sebela Pharmaceuticals Recent Developments
5.5 Allergan
5.5.1 Allergan Profile
5.5.2 Allergan Main Business
5.5.3 Allergan Irritable Bowel Syndrome Drug Products, Services and Solutions
5.5.4 Allergan Irritable Bowel Syndrome Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Allergan Recent Developments
6 North America
6.1 North America Irritable Bowel Syndrome Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Irritable Bowel Syndrome Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Irritable Bowel Syndrome Drug Market Dynamics
11.1 Irritable Bowel Syndrome Drug Industry Trends
11.2 Irritable Bowel Syndrome Drug Market Drivers
11.3 Irritable Bowel Syndrome Drug Market Challenges
11.4 Irritable Bowel Syndrome Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Irritable Bowel Syndrome Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Irritable Bowel Syndrome Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Irritable Bowel Syndrome Drug Market Size Share by Region (2018-2024)
Table 4. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Irritable Bowel Syndrome Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Irritable Bowel Syndrome Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Irritable Bowel Syndrome Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Irritable Bowel Syndrome Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Irritable Bowel Syndrome Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Irritable Bowel Syndrome Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Irritable Bowel Syndrome Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Irritable Bowel Syndrome Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Irritable Bowel Syndrome Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Irritable Bowel Syndrome Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Irritable Bowel Syndrome Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Irritable Bowel Syndrome Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Irritable Bowel Syndrome Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Irritable Bowel Syndrome Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Irritable Bowel Syndrome Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Irritable Bowel Syndrome Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Irritable Bowel Syndrome Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Irritable Bowel Syndrome Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Irritable Bowel Syndrome Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Irritable Bowel Syndrome Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Irritable Bowel Syndrome Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Irritable Bowel Syndrome Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Irritable Bowel Syndrome Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Irritable Bowel Syndrome Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Irritable Bowel Syndrome Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Irritable Bowel Syndrome Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Irritable Bowel Syndrome Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2022)
Table 39. Date of Key Players Enter into Irritable Bowel Syndrome Drug Market
Table 40. Global Irritable Bowel Syndrome Drug Key Players Headquarters and Area Served
Table 41. Irritable Bowel Syndrome Drug Product Solution and Service
Table 42. Global Irritable Bowel Syndrome Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Ironwood Pharmaceuticals Basic Information List
Table 45. Ironwood Pharmaceuticals Description and Business Overview
Table 46. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Irritable Bowel Syndrome Drug Business of Ironwood Pharmaceuticals (2018-2024)
Table 48. Ironwood Pharmaceuticals Recent Developments
Table 49. Bausch Health Basic Information List
Table 50. Bausch Health Description and Business Overview
Table 51. Bausch Health Irritable Bowel Syndrome Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Irritable Bowel Syndrome Drug Business of Bausch Health (2018-2024)
Table 53. Bausch Health Recent Developments
Table 54. Takeda Basic Information List
Table 55. Takeda Description and Business Overview
Table 56. Takeda Irritable Bowel Syndrome Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Irritable Bowel Syndrome Drug Business of Takeda (2018-2024)
Table 58. Takeda Recent Developments
Table 59. Sebela Pharmaceuticals Basic Information List
Table 60. Sebela Pharmaceuticals Description and Business Overview
Table 61. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Irritable Bowel Syndrome Drug Business of Sebela Pharmaceuticals (2018-2024)
Table 63. Sebela Pharmaceuticals Recent Developments
Table 64. Allergan Basic Information List
Table 65. Allergan Description and Business Overview
Table 66. Allergan Irritable Bowel Syndrome Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Irritable Bowel Syndrome Drug Business of Allergan (2018-2024)
Table 68. Allergan Recent Developments
Table 69. North America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 70. North America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 71. Europe Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 72. Europe Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 73. Asia-Pacific Irritable Bowel Syndrome Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 74. Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2018-2024) & (US$ Million)
Table 75. Asia-Pacific Irritable Bowel Syndrome Drug Market Size by Region (2024-2029) & (US$ Million)
Table 76. Asia-Pacific Irritable Bowel Syndrome Drug Market Share by Region (2018-2024)
Table 77. Asia-Pacific Irritable Bowel Syndrome Drug Market Share by Region (2024-2029)
Table 78. Latin America Irritable Bowel Syndrome Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 79. Latin America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 80. Latin America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 81. Middle East & Africa Irritable Bowel Syndrome Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 83. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 84. Irritable Bowel Syndrome Drug Market Trends
Table 85. Irritable Bowel Syndrome Drug Market Drivers
Table 86. Irritable Bowel Syndrome Drug Market Challenges
Table 87. Irritable Bowel Syndrome Drug Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Irritable Bowel Syndrome Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Irritable Bowel Syndrome Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Irritable Bowel Syndrome Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Irritable Bowel Syndrome Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Irritable Bowel Syndrome Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Irritable Bowel Syndrome Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Irritable Bowel Syndrome Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Irritable Bowel Syndrome Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of IBS-D Drugs
Figure 11. Global IBS-D Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of IBS-C Drugs
Figure 13. Global IBS-C Drugs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Irritable Bowel Syndrome Drug Market Size Share by Type: 2022 & 2029
Figure 17. North America Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2029)
Figure 18. Europe Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2029)
Figure 22. Women Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Men Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global Irritable Bowel Syndrome Drug Market Size Share by Application: 2022 & 2029
Figure 25. North America Irritable Bowel Syndrome Drug Revenue Market Share by Application (2018-2029)
Figure 26. Europe Irritable Bowel Syndrome Drug Revenue Market Share by Application (2018-2029)
Figure 27. Asia-Pacific Irritable Bowel Syndrome Drug Revenue Market Share by Application (2018-2029)
Figure 28. Latin America Irritable Bowel Syndrome Drug Revenue Market Share by Application (2018-2029)
Figure 29. Middle East and Africa Irritable Bowel Syndrome Drug Revenue Market Share by Application (2018-2029)
Figure 30. Irritable Bowel Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Irritable Bowel Syndrome Drug Market Share in 2022
Figure 32. North America Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 33. United States Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 34. Canada Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 35. Germany Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 36. France Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 37. U.K. Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 38. Italy Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Russia Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific Irritable Bowel Syndrome Drug Market Share by Region (2018-2029)
Figure 42. China Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Japan Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 44. South Korea Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 46. India Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 47. Australia Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Latin America Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 49. Mexico Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 50. Brazil Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 52. Turkey Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 54. UAE Irritable Bowel Syndrome Drug Market Size (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report